Data protection Impressum

Healthcare

Researchers from HUG and UNIGE have developed patient-derived lung cancer “mini-tumors” to rapidly identify the most effective personalized treatments.

Geneva team develops lung cancer “mini-tumors” to accelerate personalized treatments

13 August 2025

Researchers at the University of Geneva have uncovered that astrocytes in the brain’s cortex originate from two distinct types of progenitors, a finding that could reshape therapeutic strategies for neurological disorders.

University of Geneva researchers uncover two distinct origins of key brain cells

11 August 2025

Two start-ups from Western Switzerland’s Health Valley, AzureCell Therapies and Myriad Optics, have each been awarded CHF 150,000 through the Gebert Rüf Stiftung’s Innobooster programme, which supports high-potential projects emerging from Swiss universities.

AzureCell Therapies and Myriad Optics awarded by Gebert Rüf Stiftung’s Innobooster programme

11 August 2025

Swiss start-ups raised CHF 1.47 billion in the first half of 2025, with biotech and fintech driving growth despite fewer deals and cautious investor sentiment.

Swiss start-ups attract CHF 1.47 billion in first half of 2025

15 July 2025

Bern-based medtech Compremium is testing its compressibility-based device in patients with thyroid nodules to improve diagnostic precision and reduce unnecessary surgeries.

Compremium launches human study for non-invasive thyroid cancer diagnostic

15 July 2025

Neuchâtel, renowned globally for its watchmaking heritage, has evolved into a dynamic hub of cutting-edge innovation. Today, the canton leverages its tradition of precision craftsmanship to excel in fields as diverse as blockchain, quantum technology, renewable energy, life sciences, and advanced manufacturing. The canton of Neuchâtel’s transformation highlights its unique ability to merge historical excellence with visionary innovation, positioning itself as a leading force within Switzerland’s economic landscape.

Why Switzerland

Neuchâtel, a legacy of precision driving tomorrow’s innovation

Vaud-based medtech Comphya strengthens its clinical pipeline with fresh capital and prepares for pivotal trials in the United States.

Comphya raises CHF 7.5 million for its neurostimulation therapy to treat erectile dysfunction

14 July 2025

Geneva-based biotech Stalicla secures funding to advance precision medicine programs for autism and substance use disorders.

Addex Therapeutics leads CHF 2 million investment in Stalicla

14 July 2025

Geneva strengthens its support for breakthrough innovation with new FIF funding awarded to InTeeth, Speqqle, and 4D-PicoSense.

Three Geneva start-ups receive support from the FONGIT Innovation Fund

9 July 2025

Neuchâtel-based Aktiia has received FDA clearance for its Hilo Band, marking a global first in cuffless blood pressure monitoring for consumer use.

Aktiia’s Hilo band becomes first cuffless blood pressure monitor cleared by FDA

8 July 2025

1 2 3 4 5 … 20